Skip to main content
Top
Published in: Virology Journal 1/2013

Open Access 01-12-2013 | Research

Establishment of cell lines with increased susceptibility to EV71/CA16 by stable overexpression of SCARB2

Authors: Xiaojun Li, Peihu Fan, Jun Jin, Weiheng Su, Dong An, Lin Xu, Shiyang Sun, Yan Zhang, Xiangyu Meng, Feng Gao, Wei Kong, Chunlai Jiang

Published in: Virology Journal | Issue 1/2013

Login to get access

Abstract

Background

Human enterovirus type 71 (EV71) and Coxsackievirus A group type 16 (CA16) belong to human Enterovirus species A of the family Picornaviridae. These viruses are recognized as the major pathogens responsible for epidemics of hand-foot-mouth disease (HFMD), which presents with fever and vesicular eruptions of palms, soles of the feet or mouth. Human scavenger receptor class B, member 2 (SCARB2) has been identified as the receptor for both EV71 and CA16, as overexpression of SCARB2 in cells can enhance virus replication significantly.

Methods

In this study, we used a lentivirus packaging vector to transduce the SCARB2 gene into human embryonic kidney cells (293), human rhabdomyosarcoma cells (RD) and African green monkey kidney cells (Vero) to create stable expression lines. Expression of SCARB2 in the resulting three transgenic cell lines was confirmed by real-time RT-PCR, immunofluorescence and flow cytometry.

Results

Levels of SCARB2 mRNA determined by real-time RT-PCR in 293-SCARB2 (293S) or RD-SCARB2 (RDS) transgenic cell lines were approximately 2 × 102 times higher than those in 293 and RD cells, respectively, and three times higher in Vero-SCARB2 (VeroS) than in Vero cells. Furthermore, EV71 and CA16 virus titers in 293S and RDS cells were 102–103-fold higher (detected in RD cell) than those in the parental cells, and a 10-fold higher titer of EV71 was achieved in VeroS cells compared with that in Vero cells.

Conclusions

We established for the first time three cell lines stably overexpressing SCARB2, which showed drastic increases in susceptibility to EV71/CA16 infection. These optimal cell lines may be utilized to develop inactivated vaccines for EV71/CA16 and facilitate rapid detection and isolation of HFMD pathogens or other Enterovirus serotypes. Furthermore, these stable cell lines also can serve as tools to facilitate drug screenings as well as molecular studies on virus-host interactions and pathogenesis of causative agents for HFMD.
Appendix
Available only for authorised users
Literature
1.
go back to reference Oberste MS, Maher K, Kilpatrick DR, Pallansch MA: Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification. J Virol. 1999, 73: 1941-1948.PubMedPubMedCentral Oberste MS, Maher K, Kilpatrick DR, Pallansch MA: Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification. J Virol. 1999, 73: 1941-1948.PubMedPubMedCentral
2.
go back to reference McMinn PC: An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev. 2002, 26: 91-107. 10.1111/j.1574-6976.2002.tb00601.x.PubMedCrossRef McMinn PC: An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev. 2002, 26: 91-107. 10.1111/j.1574-6976.2002.tb00601.x.PubMedCrossRef
3.
go back to reference Qiu J: Enterovirus 71 infection: a new threat to global public health?. Lancet Neurol. 2008, 7: 868-869. 10.1016/S1474-4422(08)70207-2.PubMedCrossRef Qiu J: Enterovirus 71 infection: a new threat to global public health?. Lancet Neurol. 2008, 7: 868-869. 10.1016/S1474-4422(08)70207-2.PubMedCrossRef
4.
go back to reference Fujimoto T, Chikahira M, Yoshida S, Ebira H, Hasegawa A, Totsuka A, Nishio O: Outbreak of central nervous system disease associated with hand, foot, and mouth disease in Japan during the summer of 2000: detection and molecular epidemiology of enterovirus 71. Microbiol Immunol. 2002, 46: 621-627.PubMedCrossRef Fujimoto T, Chikahira M, Yoshida S, Ebira H, Hasegawa A, Totsuka A, Nishio O: Outbreak of central nervous system disease associated with hand, foot, and mouth disease in Japan during the summer of 2000: detection and molecular epidemiology of enterovirus 71. Microbiol Immunol. 2002, 46: 621-627.PubMedCrossRef
5.
go back to reference Chan LG, Parashar UD, Lye MS, Ong FG, Zaki SR, Alexander JP, Ho KK, Han LL, Pallansch MA, Suleiman AB, et al: Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group. Clin Infect Dis. 2000, 31: 678-683. 10.1086/314032.PubMedCrossRef Chan LG, Parashar UD, Lye MS, Ong FG, Zaki SR, Alexander JP, Ho KK, Han LL, Pallansch MA, Suleiman AB, et al: Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group. Clin Infect Dis. 2000, 31: 678-683. 10.1086/314032.PubMedCrossRef
6.
go back to reference Ho M, Chen ER, Hsu KH, Twu SJ, Chen KT, Tsai SF, Wang JR, Shih SR: An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N Engl J Med. 1999, 341: 929-935. 10.1056/NEJM199909233411301.PubMedCrossRef Ho M, Chen ER, Hsu KH, Twu SJ, Chen KT, Tsai SF, Wang JR, Shih SR: An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N Engl J Med. 1999, 341: 929-935. 10.1056/NEJM199909233411301.PubMedCrossRef
7.
8.
go back to reference Melnick JL, Schmidt NJ, Mirkovic RR, Chumakov MP, Lavrova IK, Voroshilova MK: Identification of Bulgarian strain 258 of enterovirus 71. Intervirology. 1980, 12: 297-302.PubMedCrossRef Melnick JL, Schmidt NJ, Mirkovic RR, Chumakov MP, Lavrova IK, Voroshilova MK: Identification of Bulgarian strain 258 of enterovirus 71. Intervirology. 1980, 12: 297-302.PubMedCrossRef
9.
go back to reference Perez-Velez CM, Anderson MS, Robinson CC, McFarland EJ, Nix WA, Pallansch MA, Oberste MS, Glode MP: Outbreak of neurologic enterovirus type 71 disease: a diagnostic challenge. Clin Infect Dis. 2007, 45: 950-957. 10.1086/521895.PubMedCrossRef Perez-Velez CM, Anderson MS, Robinson CC, McFarland EJ, Nix WA, Pallansch MA, Oberste MS, Glode MP: Outbreak of neurologic enterovirus type 71 disease: a diagnostic challenge. Clin Infect Dis. 2007, 45: 950-957. 10.1086/521895.PubMedCrossRef
10.
go back to reference Xu J, Qian Y, Wang S, Serrano JM, Li W, Huang Z, Lu S: EV71: an emerging infectious disease vaccine target in the Far East?. Vaccine. 2010, 28: 3516-3521. 10.1016/j.vaccine.2010.03.003.PubMedCrossRef Xu J, Qian Y, Wang S, Serrano JM, Li W, Huang Z, Lu S: EV71: an emerging infectious disease vaccine target in the Far East?. Vaccine. 2010, 28: 3516-3521. 10.1016/j.vaccine.2010.03.003.PubMedCrossRef
11.
go back to reference Ooi MH, Wong SC, Lewthwaite P, Cardosa MJ, Solomon T: Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol. 2010, 9: 1097-1105. 10.1016/S1474-4422(10)70209-X.PubMedCrossRef Ooi MH, Wong SC, Lewthwaite P, Cardosa MJ, Solomon T: Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol. 2010, 9: 1097-1105. 10.1016/S1474-4422(10)70209-X.PubMedCrossRef
12.
go back to reference Perez-Ruiz M, Navarro-Mari JM, Palacios del Valle E, Rosa-Fraile M: Human rhabdomyosarcoma cells for rapid detection of enteroviruses by shell-vial assay. J Med Microbiol. 2003, 52: 789-791. 10.1099/jmm.0.05237-0.PubMedCrossRef Perez-Ruiz M, Navarro-Mari JM, Palacios del Valle E, Rosa-Fraile M: Human rhabdomyosarcoma cells for rapid detection of enteroviruses by shell-vial assay. J Med Microbiol. 2003, 52: 789-791. 10.1099/jmm.0.05237-0.PubMedCrossRef
13.
go back to reference Sawyer MH: Enterovirus infections: diagnosis and treatment. Pediatr Infect Dis J. 1999, 18: 1033-1039. 10.1097/00006454-199912000-00002. quiz 1040PubMedCrossRef Sawyer MH: Enterovirus infections: diagnosis and treatment. Pediatr Infect Dis J. 1999, 18: 1033-1039. 10.1097/00006454-199912000-00002. quiz 1040PubMedCrossRef
14.
go back to reference Liu CC, Chou AH, Lien SP, Lin HY, Liu SJ, Chang JY, Guo MS, Chow YH, Yang WS, Chang KH, et al: Identification and characterization of a cross-neutralization epitope of Enterovirus 71. Vaccine. 2011, 29: 4362-4372. 10.1016/j.vaccine.2011.04.010.PubMedCrossRef Liu CC, Chou AH, Lien SP, Lin HY, Liu SJ, Chang JY, Guo MS, Chow YH, Yang WS, Chang KH, et al: Identification and characterization of a cross-neutralization epitope of Enterovirus 71. Vaccine. 2011, 29: 4362-4372. 10.1016/j.vaccine.2011.04.010.PubMedCrossRef
15.
go back to reference Chen Y, Li C, He D, Cheng T, Ge S, Shih JW, Zhao Q, Chen PJ, Zhang J, Xia N: Antigenic analysis of divergent genotypes human Enterovirus 71 viruses by a panel of neutralizing monoclonal antibodies: current genotyping of EV71 does not reflect their antigenicity. Vaccine. 2013, 31: 425-430. 10.1016/j.vaccine.2012.10.032.PubMedCrossRef Chen Y, Li C, He D, Cheng T, Ge S, Shih JW, Zhao Q, Chen PJ, Zhang J, Xia N: Antigenic analysis of divergent genotypes human Enterovirus 71 viruses by a panel of neutralizing monoclonal antibodies: current genotyping of EV71 does not reflect their antigenicity. Vaccine. 2013, 31: 425-430. 10.1016/j.vaccine.2012.10.032.PubMedCrossRef
16.
go back to reference Jiang B, Zhang J, You X, Dong C, Cheng X, Dai X, Meng J: Diagnosis of hand, foot, and mouth disease caused by EV71 and other enteroviruses by a one-step, single tube, duplex RT-PCR. J Med Virol. 2012, 84: 1803-1808. 10.1002/jmv.23391.PubMedCrossRef Jiang B, Zhang J, You X, Dong C, Cheng X, Dai X, Meng J: Diagnosis of hand, foot, and mouth disease caused by EV71 and other enteroviruses by a one-step, single tube, duplex RT-PCR. J Med Virol. 2012, 84: 1803-1808. 10.1002/jmv.23391.PubMedCrossRef
17.
go back to reference Cheng A, Fung CP, Liu CC, Lin YT, Tsai HY, Chang SC, Chou AH, Chang JY, Jiang RH, Hsieh YC, et al: A Phase I, randomized, open-label study to evaluate the safety and immunogenicity of an enterovirus 71 vaccine. Vaccine. 2013, 31: 2471-2476. 10.1016/j.vaccine.2013.03.015.PubMedCrossRef Cheng A, Fung CP, Liu CC, Lin YT, Tsai HY, Chang SC, Chou AH, Chang JY, Jiang RH, Hsieh YC, et al: A Phase I, randomized, open-label study to evaluate the safety and immunogenicity of an enterovirus 71 vaccine. Vaccine. 2013, 31: 2471-2476. 10.1016/j.vaccine.2013.03.015.PubMedCrossRef
18.
go back to reference Chou AH, Liu CC, Chang CP, Guo MS, Hsieh SY, Yang WH, Chao HJ, Wu CL, Huang JL, Lee MS, et al: Pilot scale production of highly efficacious and stable enterovirus 71 vaccine candidates. PLoS One. 2012, 7: e34834-10.1371/journal.pone.0034834.PubMedPubMedCentralCrossRef Chou AH, Liu CC, Chang CP, Guo MS, Hsieh SY, Yang WH, Chao HJ, Wu CL, Huang JL, Lee MS, et al: Pilot scale production of highly efficacious and stable enterovirus 71 vaccine candidates. PLoS One. 2012, 7: e34834-10.1371/journal.pone.0034834.PubMedPubMedCentralCrossRef
19.
go back to reference Lin YC, Wu CN, Shih SR, Ho MS: Characterization of a Vero cell-adapted virulent strain of enterovirus 71 suitable for use as a vaccine candidate. Vaccine. 2002, 20: 2485-2493. 10.1016/S0264-410X(02)00182-2.PubMedCrossRef Lin YC, Wu CN, Shih SR, Ho MS: Characterization of a Vero cell-adapted virulent strain of enterovirus 71 suitable for use as a vaccine candidate. Vaccine. 2002, 20: 2485-2493. 10.1016/S0264-410X(02)00182-2.PubMedCrossRef
20.
go back to reference Zhang XM, Zhao HL, Wang JJ, Liao Y, Na RX, Wang LC, Liu LD, Gao JH, Tang DH, Wang CZ, Li QH: [Evaluation of immune responses and related patho-inflammatory reactions of a candidate inactivated EV71 vaccine in neonatal monkeys]. Zhonghua Yi Xue Za Zhi. 2011, 91: 1977-1981.PubMed Zhang XM, Zhao HL, Wang JJ, Liao Y, Na RX, Wang LC, Liu LD, Gao JH, Tang DH, Wang CZ, Li QH: [Evaluation of immune responses and related patho-inflammatory reactions of a candidate inactivated EV71 vaccine in neonatal monkeys]. Zhonghua Yi Xue Za Zhi. 2011, 91: 1977-1981.PubMed
21.
go back to reference Nishimura Y, Shimojima M, Tano Y, Miyamura T, Wakita T, Shimizu H: Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat Med. 2009, 15: 794-797. 10.1038/nm.1961.PubMedCrossRef Nishimura Y, Shimojima M, Tano Y, Miyamura T, Wakita T, Shimizu H: Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat Med. 2009, 15: 794-797. 10.1038/nm.1961.PubMedCrossRef
22.
go back to reference Yamayoshi S, Yamashita Y, Li J, Hanagata N, Minowa T, Takemura T, Koike S: Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat Med. 2009, 15: 798-801. 10.1038/nm.1992.PubMedCrossRef Yamayoshi S, Yamashita Y, Li J, Hanagata N, Minowa T, Takemura T, Koike S: Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat Med. 2009, 15: 798-801. 10.1038/nm.1992.PubMedCrossRef
23.
go back to reference Eskelinen EL, Tanaka Y, Saftig P: At the acidic edge: emerging functions for lysosomal membrane proteins. Trends Cell Biol. 2003, 13: 137-145. 10.1016/S0962-8924(03)00005-9.PubMedCrossRef Eskelinen EL, Tanaka Y, Saftig P: At the acidic edge: emerging functions for lysosomal membrane proteins. Trends Cell Biol. 2003, 13: 137-145. 10.1016/S0962-8924(03)00005-9.PubMedCrossRef
24.
go back to reference Kuronita T, Eskelinen EL, Fujita H, Saftig P, Himeno M, Tanaka Y: A role for the lysosomal membrane protein LGP85 in the biogenesis and maintenance of endosomal and lysosomal morphology. J Cell Sci. 2002, 115: 4117-4131. 10.1242/jcs.00075.PubMedCrossRef Kuronita T, Eskelinen EL, Fujita H, Saftig P, Himeno M, Tanaka Y: A role for the lysosomal membrane protein LGP85 in the biogenesis and maintenance of endosomal and lysosomal morphology. J Cell Sci. 2002, 115: 4117-4131. 10.1242/jcs.00075.PubMedCrossRef
25.
go back to reference Yamayoshi S, Ohka S, Fujii K, Koike S: Functional comparison of SCARB2 and PSGL1 as receptors for enterovirus 71. J Virol. 2013, 87: 3335-3347. 10.1128/JVI.02070-12.PubMedPubMedCentralCrossRef Yamayoshi S, Ohka S, Fujii K, Koike S: Functional comparison of SCARB2 and PSGL1 as receptors for enterovirus 71. J Virol. 2013, 87: 3335-3347. 10.1128/JVI.02070-12.PubMedPubMedCentralCrossRef
26.
go back to reference Yamayoshi S, Iizuka S, Yamashita T, Minagawa H, Mizuta K, Okamoto M, Nishimura H, Sanjoh K, Katsushima N, Itagaki T, et al: Human SCARB2-dependent infection by coxsackievirus A7, A14, and A16 and enterovirus 71. J Virol. 2012, 86: 5686-5696. 10.1128/JVI.00020-12.PubMedPubMedCentralCrossRef Yamayoshi S, Iizuka S, Yamashita T, Minagawa H, Mizuta K, Okamoto M, Nishimura H, Sanjoh K, Katsushima N, Itagaki T, et al: Human SCARB2-dependent infection by coxsackievirus A7, A14, and A16 and enterovirus 71. J Virol. 2012, 86: 5686-5696. 10.1128/JVI.00020-12.PubMedPubMedCentralCrossRef
27.
go back to reference Yamayoshi S, Fujii K, Koike S: Scavenger receptor b2 as a receptor for hand, foot, and mouth disease and severe neurological diseases. Front Microbiol. 2012, 3: 32-PubMedPubMedCentralCrossRef Yamayoshi S, Fujii K, Koike S: Scavenger receptor b2 as a receptor for hand, foot, and mouth disease and severe neurological diseases. Front Microbiol. 2012, 3: 32-PubMedPubMedCentralCrossRef
28.
go back to reference Terletskaia-Ladwig E, Meier S, Hahn R, Leinmuller M, Schneider F, Enders M: A convenient rapid culture assay for the detection of enteroviruses in clinical samples: comparison with conventional cell culture and RT-PCR. J Med Microbiol. 2008, 57: 1000-1006. 10.1099/jmm.0.47799-0.PubMedCrossRef Terletskaia-Ladwig E, Meier S, Hahn R, Leinmuller M, Schneider F, Enders M: A convenient rapid culture assay for the detection of enteroviruses in clinical samples: comparison with conventional cell culture and RT-PCR. J Med Microbiol. 2008, 57: 1000-1006. 10.1099/jmm.0.47799-0.PubMedCrossRef
29.
go back to reference Bourlet T, Gharbi J, Omar S, Aouni M, Pozzetto B: Comparison of a rapid culture method combining an immunoperoxidase test and a group specific anti-VP1 monoclonal antibody with conventional virus isolation techniques for routine detection of enteroviruses in stools. J Med Virol. 1998, 54: 204-209. 10.1002/(SICI)1096-9071(199803)54:3<204::AID-JMV11>3.0.CO;2-H.PubMedCrossRef Bourlet T, Gharbi J, Omar S, Aouni M, Pozzetto B: Comparison of a rapid culture method combining an immunoperoxidase test and a group specific anti-VP1 monoclonal antibody with conventional virus isolation techniques for routine detection of enteroviruses in stools. J Med Virol. 1998, 54: 204-209. 10.1002/(SICI)1096-9071(199803)54:3<204::AID-JMV11>3.0.CO;2-H.PubMedCrossRef
30.
go back to reference Kok TW, Pryor T, Payne L: Comparison of rhabdomyosarcoma, buffalo green monkey kidney epithelial, A549 (human lung epithelial) cells and human embryonic lung fibroblasts for isolation of enteroviruses from clinical samples. J Clin Virol. 1998, 11: 61-65. 10.1016/S0928-0197(98)00026-9.PubMedCrossRef Kok TW, Pryor T, Payne L: Comparison of rhabdomyosarcoma, buffalo green monkey kidney epithelial, A549 (human lung epithelial) cells and human embryonic lung fibroblasts for isolation of enteroviruses from clinical samples. J Clin Virol. 1998, 11: 61-65. 10.1016/S0928-0197(98)00026-9.PubMedCrossRef
31.
go back to reference Buck GE, Wiesemann M, Stewart L: Comparison of mixed cell culture containing genetically engineered BGMK and CaCo-2 cells (Super E-Mix) with RT-PCR and conventional cell culture for the diagnosis of enterovirus meningitis. J Clin Virol. 2002, 25 (Suppl 1): S13-S18.PubMedCrossRef Buck GE, Wiesemann M, Stewart L: Comparison of mixed cell culture containing genetically engineered BGMK and CaCo-2 cells (Super E-Mix) with RT-PCR and conventional cell culture for the diagnosis of enterovirus meningitis. J Clin Virol. 2002, 25 (Suppl 1): S13-S18.PubMedCrossRef
32.
go back to reference Chen P, Song Z, Qi Y, Feng X, Xu N, Sun Y, Wu X, Yao X, Mao Q, Li X, et al: Molecular determinants of enterovirus 71 viral entry: cleft around GLN-172 on VP1 protein interacts with variable region on scavenge receptor B 2. J Biol Chem. 2012, 287: 6406-6420. 10.1074/jbc.M111.301622.PubMedPubMedCentralCrossRef Chen P, Song Z, Qi Y, Feng X, Xu N, Sun Y, Wu X, Yao X, Mao Q, Li X, et al: Molecular determinants of enterovirus 71 viral entry: cleft around GLN-172 on VP1 protein interacts with variable region on scavenge receptor B 2. J Biol Chem. 2012, 287: 6406-6420. 10.1074/jbc.M111.301622.PubMedPubMedCentralCrossRef
33.
go back to reference Barrett PN, Mundt W, Kistner O, Howard MK: Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines. Expert Rev Vaccines. 2009, 8: 607-618. 10.1586/erv.09.19.PubMedCrossRef Barrett PN, Mundt W, Kistner O, Howard MK: Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines. Expert Rev Vaccines. 2009, 8: 607-618. 10.1586/erv.09.19.PubMedCrossRef
34.
go back to reference Hofmann A, Kessler B, Ewerling S, Weppert M, Vogg B, Ludwig H, Stojkovic M, Boelhauve M, Brem G, Wolf E, Pfeifer A: Efficient transgenesis in farm animals by lentiviral vectors. EMBO Rep. 2003, 4: 1054-1060. 10.1038/sj.embor.7400007.PubMedPubMedCentralCrossRef Hofmann A, Kessler B, Ewerling S, Weppert M, Vogg B, Ludwig H, Stojkovic M, Boelhauve M, Brem G, Wolf E, Pfeifer A: Efficient transgenesis in farm animals by lentiviral vectors. EMBO Rep. 2003, 4: 1054-1060. 10.1038/sj.embor.7400007.PubMedPubMedCentralCrossRef
36.
go back to reference McGrew MJ, Sherman A, Ellard FM, Lillico SG, Gilhooley HJ, Kingsman AJ, Mitrophanous KA, Sang H: Efficient production of germline transgenic chickens using lentiviral vectors. EMBO Rep. 2004, 5: 728-733. 10.1038/sj.embor.7400171.PubMedPubMedCentralCrossRef McGrew MJ, Sherman A, Ellard FM, Lillico SG, Gilhooley HJ, Kingsman AJ, Mitrophanous KA, Sang H: Efficient production of germline transgenic chickens using lentiviral vectors. EMBO Rep. 2004, 5: 728-733. 10.1038/sj.embor.7400171.PubMedPubMedCentralCrossRef
37.
38.
go back to reference Farley DC, Iqball S, Smith JC, Miskin JE, Kingsman SM, Mitrophanous KA: Factors that influence VSV-G pseudotyping and transduction efficiency of lentiviral vectors-in vitro and in vivo implications. J Gene Med. 2007, 9: 345-356. 10.1002/jgm.1022.PubMedCrossRef Farley DC, Iqball S, Smith JC, Miskin JE, Kingsman SM, Mitrophanous KA: Factors that influence VSV-G pseudotyping and transduction efficiency of lentiviral vectors-in vitro and in vivo implications. J Gene Med. 2007, 9: 345-356. 10.1002/jgm.1022.PubMedCrossRef
39.
go back to reference Jin J, Han M, Xu L, An D, Kong W, Jiang C: Replication kinetics of coxsackievirus A16 in human rhabdomyosarcoma cells. Virol Sin. 2012, 27: 221-227. 10.1007/s12250-012-3245-x.PubMedCrossRef Jin J, Han M, Xu L, An D, Kong W, Jiang C: Replication kinetics of coxsackievirus A16 in human rhabdomyosarcoma cells. Virol Sin. 2012, 27: 221-227. 10.1007/s12250-012-3245-x.PubMedCrossRef
Metadata
Title
Establishment of cell lines with increased susceptibility to EV71/CA16 by stable overexpression of SCARB2
Authors
Xiaojun Li
Peihu Fan
Jun Jin
Weiheng Su
Dong An
Lin Xu
Shiyang Sun
Yan Zhang
Xiangyu Meng
Feng Gao
Wei Kong
Chunlai Jiang
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2013
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-10-250

Other articles of this Issue 1/2013

Virology Journal 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.